富祥药业: 对外信息报送和使用管理制度

Core Viewpoint - The document outlines the regulations and procedures for Jiangxi Fuxiang Pharmaceutical Co., Ltd. regarding the management of external information reporting and usage, ensuring fair disclosure and preventing insider trading. Group 1: General Provisions - The company establishes this system to enhance the standardization of periodic reports and major event disclosures, ensuring compliance with relevant laws and regulations [1] - This system applies to the company, its functional departments, subsidiaries, and all relevant personnel involved in external information reporting [1] Group 2: Management of External Information Reporting - The Board of Directors is responsible for managing external information reporting, with the Chairman as the primary responsible person and the Board Secretary overseeing the daily management [2] - Company directors and senior management must adhere to legal requirements for information disclosure and follow necessary processes for periodic and temporary reports [2] Group 3: Confidentiality Obligations - Directors and senior management have a confidentiality obligation during the preparation of periodic reports and major events, prohibiting any leaks of report content before public disclosure [3] - The company must not provide undisclosed major information or financial data to external units without legal basis prior to the disclosure of periodic reports [3] Group 4: Approval Process for External Reporting - Before external reporting, relevant personnel must fill out an external information reporting approval form, which requires approval from department heads, the financial director, and the Board Secretary [3] - The responsible personnel must ensure the authenticity, accuracy, and completeness of the reported information, while the Board Secretary is accountable for compliance with reporting procedures [3] Group 5: Responsibilities of External Units - External units or individuals are prohibited from leaking undisclosed major information and from using such information for trading the company's securities [4] - In case of a leak, the company must be notified immediately, and it will report to the Shenzhen Stock Exchange [5] Group 6: Legal Consequences - Violations of the reporting and confidentiality regulations may result in the company seeking compensation for economic losses and recovering profits from unauthorized trading activities [5] - Criminal cases related to the misuse of undisclosed information will be referred to judicial authorities [5] Group 7: Additional Provisions - Any matters not covered by this system will be executed according to relevant laws, regulations, and the company's internal management systems [6] - The Board of Directors is responsible for the formulation, modification, and interpretation of this system [6]